Comparing Ketorolac Versus Standard Opioid Pain Management After Hip Arthroscopy in Adults

What this Trial Is About

Researchers are evaluating whether ketorolac can manage pain after hip arthroscopy as well or better than standard opioid-based pain medications. The study focuses on adults over 18 years old undergoing hip arthroscopy for femoroacetabular impingement. Participants include both men and women who can consent and communicate in English. The trial aims to see if ketorolac reduces pain and the need for opioids after surgery. Participants are randomly assigned to one of two groups. The control group receives the standard pain management protocol including hydrocodone-acetaminophen, diazepam, and indomethacin. The experimental group receives ketorolac during surgery plus oral ketorolac and omeprazole after surgery, alongside the standard protocol. Medication is started on the day of surgery and continued as prescribed. Participants will take their assigned medications after discharge and keep a pain journal for 5 days, recording pain and side effects. They will complete follow-up surveys and assessments at 2 weeks, 6 weeks, and 3 months post-surgery. Researchers will measure pain using the Visual Analog Scale on day 4, track opioid use, and assess physical function and pain interference using PROMIS scores. The study monitors participants for up to 3 months to evaluate pain control and medication use.

Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy